Features
Imipenem/Cilastatin is an intravenous broad spectrum carbapenem, containing equal quantities of the antibiotic acting drug imipenem and the dehydropeptidase inhibitor cilastain.
This website uses cookies that help the website to function and also to track how you interact with it. We will only use the cookies if you consent to it by clicking on Accept. You can also manage individual cookie preference from cookie settings. Read more about the type of cookies used in our privacy notice.
Imipenem/Cilastatin is an intravenous broad spectrum carbapenem, containing equal quantities of the antibiotic acting drug imipenem and the dehydropeptidase inhibitor cilastain.
30 ml USP type 1 tubular glass vial sealed with gray bromo butyl rubber plug and aluminium flip off seal. Vial is packed individually in outer carton along with its pack insert.
The usual dose of Imipenem/Cilastatin for adults and adolescents is 500 mg every 6 hours or 1,000 mg every 6 or 8 hours. If you have kidney problems or weigh less than 70 kg, your doctor may lower your dose.
KABICILAS is indicated for the treatment of
Because of its broad spectrum bactericidal activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria, Imipenem and Cilastatin combination is useful for the treatment of mixed infections and as presumptive therapy prior to identification of causative organisms.
Consideration should be given to official guidance on the appropriate use of
anti-bacterial agents.
KabicilasTM 500
Each Vial Contains:
Imipenem IP (Sterile) equivalent to Anhydrous Imipenem ...................500mg
Cilastatin Sodium IP (Sterile) equivalent to Cilastatin ...........................500mg
SodiumBicarbonate IP (Sterile) added as buffer